Skip to content
Blerp – Lifestyle
Author:
Resalis Therapeutics SRL
Resalis Therapeutics Appoints Diana M. Røpcke as Chief Medical Officer
September 2, 2026
Resalis Announces Initiation of Phase 1b Clinical Study Evaluating RES-010 as Treatment to Address Unmet Needs in Obesity
June 29, 2026